Primary Aldosteronism Market Highlight, by type and Treatment Topmost Leading Key Players Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Bristol Laboratories Ltd (England), Outlook 2023

Primary Aldosteronism Market research report, Type (type I, type II), Indication (heart attack, kidney failure, stroke), by Diagnosis (blood test, imaging), Treatment (surgery, aldosterone antagonists), End User (hospitals) - Global forecast till 2023.

The global primary aldosteronism market is expected to grow at a CAGR of 8.40% during forecast period.

KEY PLAYERS FOR PRIMARY ALDOSTERONISM MARKET

The key players for the global primary aldosteronism market are Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Bristol Laboratories Ltd (England), CMP Pharma. (U.S.), Koninklijke Philips N.V. (The Netherlands), GE Healthcare (U.K), Siemens AG (Germany), Shimadzu Corporation (Japan), Canon Inc. (Japan), and others.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/5522 .

MARKET SCENARIO FOR PRIMARY ALDOSTERONISM MARKET

The adrenal glands within the body produce some essential hormones like aldosterone. This hormone balances the levels of sodium and potassium in the blood. Primary aldosteronism is a medical condition in which the adrenal glands produce high levels of aldosterone, causing the patient to lose potassium and retain sodium. This excess levels of sodium, increases the blood volume and blood pressure. The diagnosis and treatment of primary aldosteronism is important because it increases the risk of the heart diseases and stroke. This has provided the essential background for market growth. Factors such as increasing prevalence of primary aldosteronism and the growing geriatric population are the major drivers for the market growth. According to a study published in the International Journal of Endocrinology and Metabolism in 2016, the prevalence of the primary aldosteronism was estimated to be greater than 5%. Moreover, increasing obese population and rising consumption of alcohol is estimated to fuel the market. According to the World Health Organization, in 2016, approximately 1.9 billion adults aged 18 years or more were overweight. Moreover, it was estimated that out this population more than 650 million were obese. Additionally, rising per capita healthcare expenditure boosts the market growth.

SEGMENTATION FOR PRIMARY ALDOSTERONISM MARKET

The global primary aldosteronism market is segmented on the basis of type, indications, diagnosis, treatment and end users.

On the basis of type, the market is segmented as Type I, and Type II. On the basis of indications, the market is categorized into heart attack, kidney failure, stroke, and others. On the basis of diagnosis, the market is segmented into blood test, imaging, and others. The blood test segment is sub-segmented into aldosterone profiling, renin profiling, and others. The imaging segment is sub-segmented into computed tomography (CT), positron emission tomography (PET), and others.On the basis of end users, the market is segmented into surgery, aldosterone antagonists, and others. The aldosterone antagonists is sub-m segmented into spironolactone, eplerenone, and others.

REGIONAL ANALYSIS FOR PRIMARY ALDOSTERONISM MARKET

America dominates the global primary aldosteronism market owing to a well-developed healthcare sector and a huge patient population. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. According to the Population Reference Bureau, the American geriatric population is projected to double and reach approximately over 98 million by 2060.

Europe is the second largest market for primary aldosteronism, and is followed by Asia Pacific. Availability of funds for research, a huge patient population and government support for research & development are the driving factors for the market within the region. On a regional basis, the market is segmented into Western Europe, and Eastern Europe. The Western Europe leads the market due to the presence of developed economies like Germany, Italy, France, and others. On the other hand, Eastern Europe is estimated to be the fastest growing market.

Get Discount @ https://www.marketresearchfuture.com/check-discount/5522 .

MAJOR TOC FOR PRIMARY ALDOSTERONISM MARKET

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

LIST OF TABLES

Table 1 Primary Aldosteronism Industry Synopsis, 2017 – 2023

Table 2 Global Primary Aldosteronism Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3 Global Primary Aldosteronism Market by Region, 2017 – 2023, (USD Million)

Table 4 Global Primary Aldosteronism Market by Type, 2017 – 2023, (USD Million)

Table 5 Global Primary Aldosteronism Market by Indications, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Primary Aldosteronism Market

Figure 3 Segmentation Market Dynamics for Global Primary Aldosteronism Market

Figure 4 Global Primary Aldosteronism Market Share, By Type 2016

Figure 5 Global Primary Aldosteronism Market Share, By Indications 2016

Figure 6 Global Primary Aldosteronism Market Share, By Diagnosis 2016

Figure 7 Global Primary Aldosteronism Market Share, By Treatment 2016

TOC Continued…..

Inquire before Buying@ https://www.marketresearchfuture.com/enquiry/5522.

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.